FDA.reportPublic FDA data

tirzepatide 25 MG/ML Injectable Solution

RxCUI
2732449
RxNorm name
tirzepatide 25 MG/ML Injectable Solution
Display name
tirzepatide 25 MG/ML Injectable Solution
Full name
tirzepatide 25 MG/ML Injectable Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776btirzepatide 25 MG/ML Injectable SolutionSCD38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776btirzepatide 25 MG/ML Injectable SolutionPSN38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc0tirzepatide 25 MG/ML Injectable SolutionSCD38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc0tirzepatide 25 MG/ML Injectable SolutionPSN38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422